Head-to-head · WeighScore
Gaya Wellness vs Levers Health
The verdict
Gaya Wellness takes it — 63.9/100 to 53.3/100.
Gaya Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gaya Wellness is a virtual, OB/GYN-led telehealth practice focused on women 40+ for menopause, hormone replacement, and weight loss.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Gaya Wellness | Levers Health |
|---|---|---|
| WeighScore | 63.9/100 | 53.3/100 |
| Grade | C | C |
| Scorecard rank | #250 | #469 |
| Semaglutide | $349/mo (compounded) | $247/mo (1.25 mg dose, compounded) |
| Tirzepatide | $349/mo (compounded) | $296/mo (5 mg dose, compounded) |
| Coverage | 5 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #250 · C
Strengths
- OB/GYN-led care designed for women 40+ and menopause overlap
- Includes a 50+ biomarker lab panel and weekly physician check-ins
- HSA/FSA eligible with a GLP-1 plus bioidentical HRT bundle option
- Transparent tiered pricing published online
Where it loses points
- Weight loss is one vertical alongside menopause and hormone care
- Medication-included tiers ($349+/mo) are pricier than many compounders
- Available in only five states (FL, NC, VA, IN, TN)
Graded #469 · C
Strengths
- Named LLC entity
- Microdose GLP-1 option marketed for longevity
- Both semaglutide and tirzepatide available
Where it loses points
- No LegitScript or PCAB accreditation
- No physical address disclosed
- State availability not disclosed
- FAQ and terms pages return 404
- Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.